This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This can be mitigated through targeting modifiable riskfactors. Identification of those at-risk through screening tools could be facilitated by inclusion of self-reported riskfactors rather than reliance on clinical data.
Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular riskfactors in patients with hemophilia compared to the general population.
Compared to subjects with low CVH, participants with moderate and high CVH exhibited lower risks of 47% and 76%, respectively. Physical activity (PA), body mass index (BMI), and blood glucose were associated with aTRH (all p-values<0.05), while diet, nicotine exposure, sleep, and blood lipids were not significantly associated with aTRH.
Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major riskfactor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2. to 25 kg/m2) and underweight (BMI less than 18.5
The benefit of resistance training observed in observational studies is supported by controlled trials on resistance training, which demonstrate that this type of exercise reduces traditional and nontraditional CVD riskfactors. Of course, these benefits can also extend to individuals with a BMI in the normal range.
The benefit of resistance training observed in observational studies is supported by controlled trials on resistance training, which demonstrate that this type of exercise reduces traditional and nontraditional CVD riskfactors. Of course, these benefits can also extend to individuals with a BMI in the normal range.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content